Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
      11824 results
    
    - 
  
    
2016 PHN childhood immunisation coverage dataThese spreadsheets provide 2016 quarterly childhood immunisation coverage data by Primary Health Network (PHN), for all children and Aboriginal and Torres Strait Islander children.
- 
  
    
Literature review of international biosimilar medicines update – September to December 2016This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers September to December 2016.
- 
  
    
Administrative record keeping guidelines for health professionalsThe Administrative Record Keeping Guidelines provides useful information and tools that support good administrative record keeping within your practice.
- 
  
    
BreastScreen Australia – National Accreditation Standards (NAS) accountability framework (BSA003)BreastScreen Australia services and State Coordination Units (SCUs) use this form to identify which NAS measures they are responsible for as part of the accreditation process.
- 
  
    
Zika virus – CDNA National Guidelines for Public Health UnitsThese guidelines for Public Health Units provide nationally consistent guidance on how to respond to Zika virus. They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).
- 
  
    
Report from the General Practice and Primary Care Clinical Committee – Phase 1This interim report provided the MBS Review Taskforce with a progress update on the work of the General Practice and Primary Care Clinical Committee, as at April 2017.
- 
  
    
Biosimilar medicines – The basics for consumers and carersThis brochure provides information for consumers and carers about biosimilar medicines, including what they are, who uses them, why they’re important, and how we regulate them.
- 
  
    
Biosimilar medicines – The basics for healthcare professionalsThis brochure provides information for healthcare professionals about biosimilar medicines, including what they are, how they are developed, whether they differ from biological medicines, and how we monitor their safety.
- 
  
    
Tularaemia – Laboratory case definitionThe Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for tularaemia.
- 
  
    
Plague – Laboratory case definitionThe Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for plague.
- 
  
    
Cryptosporidiosis – Laboratory case definitionThe Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for cryptosporidiosis.
- 
  
    
Legislated Review of Aged Care 2017 ReportThis report presents the findings of the 2017 independent review of the Living Longer Living Better reforms. It includes 38 recommended actions to further improve the aged care system.
- 
  
    
Typhoid and paratyphoid – CDNA National Guidelines for Public Health UnitsThese guidelines for Public Health Units provide nationally consistent guidance on how to respond to typhoid and paratyphoid. They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).
- 
  
    
Hendra virus – CDNA National Guidelines for Public Health UnitsThis document from the Communicable Diseases Network Australia (CDNA) is for public health units. It provides nationally consistent guidance on how to respond to the Hendra virus.
- 
  
    
SSBA – Guideline 10 – Monitoring inspectionsThis guideline lets facilities know what to expect when scheduled for a monitoring inspection. It includes details about required pre-inspection actions, the inspection process itself, and potential post-inspection actions.
- 
  
    
Annual Report of the Marketing in Australia of Infant Formula Tribunal 2015–20162015–2016 Annual Report of the Marketing in Australia of Infant Formula
- 
  
    
Review of the Specialist Training Program and the Emergency Medicine Program – final reportThis report outlines the results of a review of the Specialist Training Program and Emergency Medicine Program. The review looked at the programs' operation and how training posts were allocated. It resulted in several reform proposals.
- 
  
    
COAG response to the independent Review of the National Disability Insurance Scheme Act 2013In July 2015, the Australian Government (in consultation with State and Territory governments) commissioned Ernst & Young (EY) to conduct an independent review of the National Disability Insurance Scheme Act 2013 (Cth) (NDIS Act).
- 
  
    
Review of the implementation of the national reform agenda on organ and tissue donation and transplantationAustralian Government response to the Ernst & Young report: Review of the implementation of the national reform agenda on organ and tissue donation and transplantation
- 
  
    
BreastScreen Australia NQMC – DGMA frameworkThis document outlines a framework for the Data Governance and Management Assessments (DGMA) that apply under the BreastScreen Australia Accreditation System.
- 
  
    
Australian National Breastfeeding Strategy 2010–2015 – final progress reportThis report outlines the progress that has been made across the 10 action areas for the Australian National Breastfeeding Strategy 2010–2015.
- 
  
    
2010 implementation plan for the Australian National Breastfeeding Strategy 2010–2015This plan outlines the staged approach to the implementation of the Australian National Breastfeeding Strategy 2010–2015.
- 
  
    
ANACAD summary of activities 2015–16An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from December 2014 to 30 June 2016.
- 
  
    
State and territory vaccine objection (conscientious objection) dataThese documents provide conscientious objection data by state and territory for 2012 to 2015. The data is sourced from the Australian Immunisation Register (AIR).
- 
  
    
Medicare billing assurance toolkit – strategies to minimise riskThere are 10 strategies you should adopt in your practice to identify, manage and prevent the risk of incorrect billing under Medicare.